The Influence of Biologically Active Substances Secreted by the Adipose Tissue on Endometrial Cancer
- PMID: 33799622
- PMCID: PMC8000529
- DOI: 10.3390/diagnostics11030494
The Influence of Biologically Active Substances Secreted by the Adipose Tissue on Endometrial Cancer
Abstract
Endometrial cancer is one of the most frequently diagnosed gynecological neoplasms in developed countries and its incidence is rising. Usually, it is diagnosed in the early stages of the disease and has a good prognosis; however, in later stages, the rate of recurrence reaches up to 60%. The discrepancy in relapse rates is due to the heterogeneity of the group related to the presence of prognostic factors affecting survival parameters. Increased body weight, diabetes, metabolic disturbances and estrogen imbalance are important factors for the pathogenesis of endometrial cancer. Even though prognostic factors such as histopathological grade, clinical stage, histological type and the presence of estrogen and progesterone receptors are well known in endometrial cancer, the search for novel prognostic biomarkers continues. Adipose tissue is an endocrine organ involved in metabolism, immune response and the production of biologically active substances participating in cell growth and differentiation, angiogenesis, apoptosis and carcinogenesis. In this manuscript, we review the impact of factors secreted by the adipose tissue involved in the regulation of glucose and lipid metabolism (leptin, adiponectin, omentin, vaspin, galectins) and factors responsible for homeostasis maintenance, inflammatory processes, angiogenesis and oxidative stress (IL-1β, 6, 8, TNFα, Vascular endothelial growth factor (VEGF), Fibroblast growth factors (FGFs)) in the diagnosis and prognosis of endometrial cancer.
Keywords: FGF; VEGF; adipokines; angiogenesis; cytokines; endometrial cancer; galectin; inflammation; leptin.
Conflict of interest statement
The authors declare no conflict of interest.
Figures



Similar articles
-
Evaluation of biologically active substances promoting the development of or protecting against endometrial cancer.Onco Targets Ther. 2018 Mar 13;11:1363-1372. doi: 10.2147/OTT.S155942. eCollection 2018. Onco Targets Ther. 2018. PMID: 29559794 Free PMC article.
-
Evaluation of Tissue Expression of Vaspin and Serum Vaspin Concentration as a Prognostic and Risk Factor in Endometrial Cancer.Cells. 2022 Oct 11;11(20):3196. doi: 10.3390/cells11203196. Cells. 2022. PMID: 36291064 Free PMC article.
-
Effect of angiogenesis inhibitors on oestrogen-mediated endometrial endothelial cell proliferation in the ovariectomized mouse.Reproduction. 2003 Mar;125(3):337-46. doi: 10.1530/rep.0.1250337. Reproduction. 2003. PMID: 12611597
-
Adipokines: inflammation and the pleiotropic role of white adipose tissue.Br J Nutr. 2004 Sep;92(3):347-55. doi: 10.1079/bjn20041213. Br J Nutr. 2004. PMID: 15469638 Review.
-
Alcohol intake modulates hormonal activity of adipose tissue.Endocr Regul. 2006 Sep;40(3):91-104. Endocr Regul. 2006. PMID: 17100551 Review.
Cited by
-
The Role of Omentin-1 in Cancers Development and Progression.Cancers (Basel). 2023 Jul 26;15(15):3797. doi: 10.3390/cancers15153797. Cancers (Basel). 2023. PMID: 37568613 Free PMC article. Review.
-
The Regulatory Role of Lipid Metabolism in Endometrial Cancer.J Oncol. 2022 Aug 29;2022:6458877. doi: 10.1155/2022/6458877. eCollection 2022. J Oncol. 2022. PMID: 36072980 Free PMC article. Review.
-
Palmitic Acid Exerts Anti-Tumorigenic Activities by Modulating Cellular Stress and Lipid Droplet Formation in Endometrial Cancer.Biomolecules. 2024 May 20;14(5):601. doi: 10.3390/biom14050601. Biomolecules. 2024. PMID: 38786008 Free PMC article.
-
The Relationship Between Leptin Receptor Expression and Endometrial Carcinoma; A Case-Control Study.Iran J Pathol. 2023 Spring;18(2):173-179. doi: 10.30699/ijp.2023.1972584.3017. Epub 2023 Jun 20. Iran J Pathol. 2023. PMID: 37600567 Free PMC article.
-
Adipokines as New Biomarkers of Immune Recovery: Apelin Receptor, RBP4 and ZAG Are Related to CD4+ T-Cell Reconstitution in PLHIV on Suppressive Antiretroviral Therapy.Int J Mol Sci. 2022 Feb 17;23(4):2202. doi: 10.3390/ijms23042202. Int J Mol Sci. 2022. PMID: 35216318 Free PMC article.
References
-
- Kaaks R., Berrino F., Key T., Rinaldi S., Dossus L., Biessy C., Secreto G., Amiano P., Bingham S., Boeing H., et al. Serum Sex Steroids in Premenopausal Women and Breast Cancer Risk Within the European Prospective Investigation into Cancer and Nutrition (EPIC) JNCI. 2005;97:755–765. doi: 10.1093/jnci/dji132. - DOI - PubMed
Publication types
LinkOut - more resources
Full Text Sources
Other Literature Sources